Similarly, in breast cancer, TLR5 activation in vitro inhibited tumor cell proliferation and colony formation by decreasing cyclin B1, cyclin D1 and cyclin E2 expression and increasing CDK inhibitor p27. The gene discussed is CCND1; the disease is neoplasm.